NITD-688, a pan-serotype inhibitor ofthe dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

Stephanie A. Moquin, Oliver Simon, Ratna Karuna, Suresh B. Lakshminarayana, Fumiaki Yokokawa, Feng Wang, Chandra Saravanan, Jin Zhang, Craig W. Day, Katherine Chan, Qing Yin Wang, Siyan Lu, Hongping Dong, Kah Fei Wan, Siew Pheng Lim, Wei Liu, Cheah Chen Seh, Yen Liang Chen, Haoying Xu, David T. BarkanCyrille S. Kounde, Wei Lin Sandra Sim, Gang Wang, Hui Quan Yeo, Bin Zou, Wai Ling Chan, Mei Ding, Jae Geun Song, Min Li, Colin Osborne, Francesca Blasco, Christopher Sarko, David Beer, Ghislain M.C. Bonamy, Vito G. Sasseville, Pei Yong Shi, Thierry T. Diagana, Bryan K.S. Yeung, Feng Gu

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'NITD-688, a pan-serotype inhibitor ofthe dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models'. Together they form a unique fingerprint.

Medicine & Life Sciences